Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Maori with asthma.
Pilcher J, Patel M, Smith A, Davies C, Pritchard A, Travers J, Black P, Weatherall M, Beasley R, Harwood M; SMART Study Group. Pilcher J, et al. Respirology. 2014 Aug;19(6):842-51. doi: 10.1111/resp.12319. Epub 2014 Jun 2. Respirology. 2014. PMID: 24889937 Clinical Trial.
BACKGROUND AND OBJECTIVE: There are significant health disparities between Maori and non-Maori with asthma, a pattern seen between other ethnic populations. This study investigates outcomes for Maori in a randomized controlled trial (RCT) of combina …
BACKGROUND AND OBJECTIVE: There are significant health disparities between Maori and non-Maori with asthma, a pattern s …
Combination budesonide/formoterol inhaler as sole reliever therapy in Maori and Pacific people with mild and moderate asthma.
Hardy J, Tewhaiti-Smith J, Baggott C, Fingleton J, Semprini A, Holliday M, Hancox RJ, Weatherall M, Harwood M. Hardy J, et al. N Z Med J. 2020 Aug 21;133(1520):61-72. N Z Med J. 2020. PMID: 32994594 Clinical Trial.
AIM: In the PRACTICAL study, as-needed budesonide/formoterol reduced the rate of severe exacerbations compared with maintenance budesonide plus as-needed terbutaline. ...CONCLUSION: The reduction in severe exacerbation risk with budesonide-formotero …
AIM: In the PRACTICAL study, as-needed budesonide/formoterol reduced the rate of severe exacerbations compared with mainten …
Predictors of severe exacerbations, poor asthma control, and beta-agonist overuse for patients with asthma.
Patel M, Pilcher J, Reddel HK, Qi V, Mackey B, Tranquilino T, Shaw D, Black P, Weatherall M, Beasley R; SMART Study Group. Patel M, et al. J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):751-8. doi: 10.1016/j.jaip.2014.06.001. Epub 2014 Jul 25. J Allergy Clin Immunol Pract. 2014. PMID: 25439367 Clinical Trial.
OBJECTIVE: To investigate characteristics that predict subsequent adverse outcomes in asthma. METHODS: An independent 24-week, randomized controlled trial of 303 adult patients with asthma who are at risk, which compared the efficacy of SMART (single budesonide …
OBJECTIVE: To investigate characteristics that predict subsequent adverse outcomes in asthma. METHODS: An independent 24-week, random …